, (Vxpert) [= ] 3 1 . 23 2022 (Vxpert, Vaccine + Expert) 28 . , 19 2 . ( , ) 19 2020 1 . 919 2007 2011 5 - (case-control analysis) . 3 1 , , , (RSV) . 4~5 , . , . , 29% 72% . 19 19 , 7.8(9… [+65 chars]
(19) . 15 ‘2021 ’ 2020 38.3% 2019(33.8%) 4.5%p . 19 . , , , . . 1 . ‘ 1⋅3⋅5 ’ . ‘1km ’ 2019 24.7% 2020 19.8% 4.9%p . . ‘’ . ( 1km) . , 1m . . . . 11 . . ‘ 3 ’ 19 . 40% . , , . . ‘’ … [+107 chars]
(19) . 15 ‘2021 ’ 2020 38.3% 2019(33.8%) 4.5%p . 19 . , , , . . 1 . ‘ 1⋅3⋅5 ’ . ‘1km ’ 2019 24.7% 2020 19.8% 4.9%p . . ‘’ . ( 1km) . , 1m . . . . 11 . . ‘ 3 ’ 19 . 40% . , , . . ‘’ … [+107 chars]
[= ] . 23 ( ) ‘2022 (Vxpert, Vaccine + Expert) ’ 28 . 919 5(2007~2011) - (case-control analysis) . 3 1 , , , (RSV) . , 4~5 , . . . , . " , 29% 72% " . 19 19 , 7.8(95% CI, 3.8–15.8) . … [+10 chars]
4 (COVID-19·19) . . . , 19 2 '' 25 . 19 . . 2020 2 6~2021 12 8 19 6965 . 583 . 227 , 136 , 220 (RSV) . 19 19 . 19 19 4, 2.4 . 19 RSV . 19 , . 19 . 27() "19 " " 19 " . "19 " … [+4 chars]
··· · 20 200 ( ) 2 19 . 100 . 5 , 600 . .19 , , . ACE2() . . , , , 20 . . . (NIAID) . ? . , . , . . . . () 60 . 60 . (39 ) 18~29 50 2, 25 . 75 8, 140 . (327 ) 30 0% 70 0.71%, 80 2.74% . .… [+690 chars]
